Table 3 Categories and number of individual metabolic syndrome components with its overall prevalence in the two study groups
Breast cancer N = 112 No. (%) | Control N = 112 No. (%) | Total N = 224 No. (%) | p-value * | |
|---|---|---|---|---|
FBG | ||||
< 126 mg/dl | 83 (74.1) | 102 (91.1) | 185 (82.6) | 0.001 |
≥ 126 mg/dl | 29 (25.9) | 10 (8.9) | 39 (17.4) | |
SBP | ||||
< 130 mmHg | 85 (75.9) | 100 (89.3) | 185 (82.6) | 0.008 |
≥ 130 mmHg | 27 (24.1) | 12 (10.7) | 39 (17.4) | |
DBP | ||||
< 85 mmHg | 89 (76.8) | 98 (87.5) | 184 (82.1) | 0.036 |
≥ 85 mmHg | 26 (23.2) | 14 (12.5) | 40 (17.9) | |
TG | ||||
< 150 mg/dl | 32 (28.6) | 63 (56.2) | 95 (42.4) | < 0.001 |
≥ 150 mg/dl | 80 (71.4) | 49 (43.8) | 129 (57.6) | |
HDL-c | ||||
< 50 mg/dl | 100 (89.2) | 66 (58.9) | 166 (74.5) | < 0.001 |
≥ 50 mg/dl | 12 (10.8) | 46 (41.1) | 58 (25.9) | |
WC | ||||
< 88 cm | 54 (48.2) | 50 (44.6) | 104 (46.4) | 0.592 |
≥ 88 cm | 58 (51.8) | 62 (55.4) | 120 (53.6) | |
Number of components | ||||
0 | 2 (1.8) | 17 (15.2) | 19 (8.5) | P-value for linear trend < 0.001 |
1 | 16 (14.3) | 39 (34.8) | 55 (24.6) | |
2 | 30 (26.8) | 24 (21.4) | 54 (24.1) | |
3 | 36 (32.1) | 25 (22.4) | 61 (27.2) | |
4 | 24 (21.4) | 6 (5.4) | 30 (13.4) | |
5 | 4 (3.6) | 1 (0.8) | 5 (2.2) | |
Overall prevalence of MS | ||||
< 3 components | 48 (42.9) | 80 (71.4) | 128 (57.1) | < 0.001 |
≥ 3 components | 64 (57.1) | 32 (28.6) | 96 (42.9) | |